21514523

Source:http://linkedlifedata.com/resource/pubmed/id/21514523

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0005767, umls-concept:C0030705, umls-concept:C0038952, umls-concept:C0456603, umls-concept:C0681842, umls-concept:C0796679, umls-concept:C1519810, umls-concept:C2239176
pubmed:issue	5
pubmed:dateCreated	2011-4-25
pubmed:abstractText	To evaluate whether the neutrophil-to-lymphocyte ratio (NLR) predicts survival in patients with unresectable hepatocellular carcinoma (HCC) before and after transarterial chemoembolization treatment.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9203369
pubmed:citationSubset	IM
pubmed:status	MEDLINE
pubmed:month	May
pubmed:issn	1535-7732
pubmed:author	pubmed-author:ChenMin-ShanMS, pubmed-author:HuangZhi-LiangZL, pubmed-author:LiJin-QingJQ, pubmed-author:NellL JLJ, pubmed-author:PaiR KRK
pubmed:copyrightInfo	Copyright © 2011 SIR. Published by Elsevier Inc. All rights reserved.
pubmed:issnType	Electronic
pubmed:volume	22
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	702-9
pubmed:meshHeading	pubmed-meshheading:21514523-Carcinoma, Hepatocellular, pubmed-meshheading:21514523-Chemoembolization, Therapeutic, pubmed-meshheading:21514523-Chi-Square Distribution, pubmed-meshheading:21514523-China, pubmed-meshheading:21514523-Female, pubmed-meshheading:21514523-Humans, pubmed-meshheading:21514523-Kaplan-Meier Estimate, pubmed-meshheading:21514523-Liver Neoplasms, pubmed-meshheading:21514523-Lymphocyte Count, pubmed-meshheading:21514523-Lymphocytes, pubmed-meshheading:21514523-Male, pubmed-meshheading:21514523-Middle Aged, pubmed-meshheading:21514523-Neutrophils, pubmed-meshheading:21514523-Proportional Hazards Models, pubmed-meshheading:21514523-Retrospective Studies, pubmed-meshheading:21514523-Risk Assessment, pubmed-meshheading:21514523-Risk Factors, pubmed-meshheading:21514523-Survival Rate, pubmed-meshheading:21514523-Time Factors, pubmed-meshheading:21514523-Treatment Outcome
pubmed:year	2011
pubmed:articleTitle	Blood neutrophil-to-lymphocyte ratio predicts survival in patients with unresectable hepatocellular carcinoma undergoing transarterial chemoembolization.
pubmed:affiliation	Department of Hepatobiliary Oncology, Cancer Center, Sun Yat-sen University, Guangzhou, 510060, PR China.
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't